|
Geographic area covered by the project
| | | | | | |
|
Regional
|
4
|
3
|
5
|
6
|
18 (62)
|
2, 4, 5, 7, 8, 10, 11, 13, 14, 16, 17, 20, 21, 22, 26, 27, 28, 29
|
|
National
|
0
|
1
|
3
|
6
|
10 (34)
|
1, 3, 6, 9, 15, 18, 19, 23, 24, 25
|
|
International
|
0
|
0
|
0
|
1
|
1 (3)
|
12
|
|
Area covered by the project
| | | | | | |
|
Hospital
|
4
|
2
|
5
|
4
|
15 (52)
|
2, 4, 5, 8, 11, 13, 17, 18, 20, 21, 22, 26, 27, 28, 29
|
|
Community
|
0
|
0
|
0
|
6
|
6 (21)
|
1, 3, 12, 14, 15, 16
|
|
Primary care
|
0
|
2
|
1
|
1
|
4 (14)
|
6, 7, 9, 10
|
|
Other healthcare institutions (different from hospitals or primary care)
|
0
|
0
|
1
|
2
|
3 (10)
|
19, 24, 25
|
|
Clinical trials
|
0
|
0
|
1
|
0
|
1 (3)
|
23
|
|
Type of action promoted by the project
| | | | | | |
|
Passive promotion of ADR reporting
|
3
|
3
|
6
|
10
|
22 (76)
|
4, 5, 6, 8, 9, 10, 11, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 29
|
|
Active promotion of ADR reporting
|
1
|
1
|
2
|
3
|
7 (24)
|
1, 2, 3, 7, 12, 13, 28
|
|
Type of software
| | | | | | |
|
Web-based
|
1
|
3
|
6
|
6
|
16 (55)
|
2, 3, 5, 7, 9, 12, 13, 14, 15, 16, 19, 20, 22, 23, 27, 28
|
|
System inside the Electronic Health Record
|
3
|
1
|
2
|
6
|
12 (41)
|
4, 6, 8, 10, 11, 17, 21, 24, 25, 26, 18, 29
|
|
Mobile
|
0
|
0
|
0
|
1
|
1 (3)
|
1
|
|
Type of institution promoting the study
| | | | | | |
|
Hospital
|
2
|
1
|
3
|
3
|
9 (31)
|
2, 4, 8, 17, 18, 21, 26, 27, 29
|
|
University
|
1
|
1
|
3
|
4
|
9 (31)
|
5, 10, 11, 12, 13, 19, 20, 24, 25
|
|
National institution
|
0
|
2
|
0
|
2
|
4 (14)
|
1, 9, 15, 22
|
|
Regulatory authority
|
1
|
0
|
1
|
3
|
5 (17)
|
6, 7, 14, 16, 28
|
|
Othera
|
0
|
0
|
1
|
1
|
2 (7)
|
3, 23
|
|
Target
| | | | | | |
|
Healthcare professionals
|
4
|
2
|
7
|
8
|
21 (72)
|
4, 6, 7, 8, 9, 10, 11, 13, 14, 16, 17, 18, 19, 21, 23, 24, 25, 26, 27, 28, 29.
|
|
Patients
|
0
|
2
|
1
|
4
|
7 (24)
|
1, 2, 3, 5, 12, 20, 22
|
|
Healthcare professionals and patients
|
0
|
0
|
0
|
1
|
1 (3)
|
15
|
|
Type of medicine
| | | | | | |
|
All
|
4
|
1
|
5
|
11
|
21 (72)
|
3, 4, 5, 6, 7, 8, 9, 11, 12, 14, 16, 17, 18, 19, 20, 21, 24, 25, 26, 28, 29
|
|
Vaccines
|
0
|
2
|
1
|
2
|
5 (17)
|
1, 10, 13, 15, 22
|
|
Chemotherapy
|
0
|
1
|
0
|
0
|
1 (3)
|
2
|
|
Human albumin
|
0
|
0
|
1
|
0
|
1 (3)
|
23
|
|
Radiopaque agents
|
0
|
0
|
1
|
0
|
1 (3)
|
27
|
|
Type of ADR
| | | | | | |
|
All
|
4
|
4
|
8
|
11
|
27 (93)
|
2, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
|
|
Serious
|
0
|
0
|
0
|
2
|
2 (7)
|
1, 3
|
